The recall covers 142 production lots of Triaminic syrups and 41 lots of Theraflu syrups. Novartis, which produces the medicines, says the defect could allow for the removal the cap without breaking the seal on the bottle. The company said it received four reports of adverse events related to the Triaminic products.
The products were made between May 2010 and December 2011 at a Novartis facility in Nebraska. Novartis shut down that plant in December 2011 after federal inspections found numerous quality-control problems. Novartis said it believes 97% of the inventory has been used, returned, or quarantined.
A full list of recalled lot and NDC numbers, along with each of the products under the recall, can be found on Novartis' website.